Vivomixx + Placebo
Phase 1/2UNKNOWN 0 watching 0 views this week💤 Quiet
36
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Breast Cancer
Conditions
Breast Cancer, Osteoporosis, Osteopenia
Trial Timeline
Jan 1, 2019 → Jun 1, 2021
NCT ID
NCT03518268About Vivomixx + Placebo
Vivomixx + Placebo is a phase 1/2 stage product being developed by Perrigo for Breast Cancer. The current trial status is unknown. This product is registered under clinical trial identifier NCT03518268. Target conditions include Breast Cancer, Osteoporosis, Osteopenia.
Hype Score Breakdown
Clinical
13
Activity
8
Company
5
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03518268 | Phase 1/2 | UNKNOWN |
Competing Products
20 competing products in Breast Cancer